REGN logo

REGN

Profile

Full Name

Regeneron Pharmaceuticals, Inc.

Ticker Symbol

REGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 2, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.regeneron.com

Employees

15106

Key Details

Price

$599.76(+2.03%)

Market cap

Last Dividend

$0.88

TTM Dividend yield

0.15%

Annual revenue

$14.20B(+8.27% YoY)

Annual EPS

$38.34(+10.27% YoY)

PE ratio

15.67

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$599.76
REGN price is $599.76

30-Day Relative Volume

1.16
REGN 30-day relative volume is 1.16

Price Performance

Price Today change

+2.03%
REGN price is up +2.03% today

Price YTD change

-15.8%
REGN price is down -15.8% since January 1st

Price 1-year change

-33.84%
REGN price is down -33.84% year-on-year

Price 3-year change

-12.84%
REGN price is down -12.84% over the past 3 years

Price Range

Price All-time high

$1211.20
REGN price is currently -50.48% below its historical high of $1211.20

Price 3-year low

$525.99
REGN price is currently +14.02% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$65.57B
REGN market capitalization is $65.57 billion

Market cap 3-year change

-13.25%
REGN market capitalization is down -13.25% over the past 3 years

Market cap All-time high

$132.20B
REGN market capitalization is currently -50.40% below its historical high of $132.20 billion

Market cap sector rank

97.68%
REGN market capitalization is higher than 97.68% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.78%
REGN shares outstanding is down -0.78% year-on-year

Shares Outstanding 3-Year Change

-0.47%
REGN shares outstanding is down -0.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.59
REGN beta is 0.59

200-day SMA

$854.00
REGN price is currently -29.77% below its 200-day simple moving average

50-day SMA

$645.23
REGN price is currently -7.05% below its 50-day simple moving average

RSI

49.26
REGN 14-day relative strength index is 49.26

Volume

1.16
REGN 30-day relative volume is 1.16

ATR

$22.41
REGN average true range is $22.41

10-day Historical Volatility

45.48%
REGN 10-day historical volatility is 45.48%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.88
REGN last dividend was $0.88 per share, with an ex-dividend date of February 20, 2025

Next Dividend

-
REGN next dividend has not yet been announced

Dividend per share

Dividend per share

-
REGN annual dividend per share value is unknown

Dividend per share Sector Rank

-
REGN annual dividend per share is unknown

Dividend per share 1-Year Change

-
REGN annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
REGN annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
REGN annual dividend yield value is unknown

Dividend yield Sector Rank

-
REGN annual dividend yield is unknown

Other

Payout ratio

-
REGN annual payout ratio value is unknown

Dividends paid

-
REGN annual dividends paid value is unknown

Free cash flow

$3.54B
REGN annual free cash flow is $3.54 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$14.20B
REGN annual revenue is $14.20 billion

Revenue Analysts estimate

$14.25B
REGN annual revenue is currently -0.31% lower than the consensus analysts' forecast

Revenue 1-year change

+8.27%
REGN annual revenue is up +8.27% year-on-year

Revenue Sector rank

95.22%
REGN annual revenue is higher than 95.22% of companies in Healthcare sector

EPS

EPS

$38.34
REGN annual earnings per share is $38.34

EPS Analysts estimate

$39.99
REGN annual earnings per share is currently -4.13% lower than the consensus analysts' forecast

EPS 1-year change

+10.27%
REGN annual earnings per share is up +10.27% year-on-year

EPS Sector rank

99.75%
REGN annual earnings per share is higher than 99.75% of companies in Healthcare sector

Profit

Gross profit

$12.23B
REGN annual gross profit is $12.23 billion

Gross margin

86.13%
REGN annual gross profit margin is 86.13%

Operating profit

$4.09B
REGN annual operating income is $4.09 billion

Operating margin

28.81%
REGN annual operating profit margin is 28.81%

Net income

$4.41B
REGN annual net profit is $4.41 billion

Net margin

31.07%
REGN annual net profit margin is 31.07%

Expenses

Total expenses

$10.11B
REGN annual total expenses is $10.11 billion

Operating expenses

$8.14B
REGN annual total operating expenses is $8.14 billion

Cost of goods sold

$1.97B
REGN annual cost of goods sold is $1.97 billion

Selling, general & administrative expenses

$2.95B
REGN annual SGA is $2.95 billion

Depreciation and amortization

$482.90M
REGN annual depreciation & amortization is $482.90 million

Interest expense

$55.20M
REGN annual interest expense is $55.20 million

Income tax

$367.30M
REGN annual income tax is $367.30 million

EBIT & EBITDA

EBIT

$4.84B
REGN annual earnings before interest & taxes is $4.84 billion

EBITDA

$5.32B
REGN annual EBITDA is $5.32 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$37.76B
REGN annual total assets is $37.76 billion

Non current assets

$19.10B
REGN annual long term assets is $19.10 billion

Current assets

$18.66B
REGN annual total current assets is $18.66 billion

Cash and cash equivalents

$2.49B
REGN annual cash & cash equivalents is $2.49 billion

Accounts receivable

$6.21B
REGN annual accounts receivable is $6.21 billion

Inventory

$3.09B
REGN annual inventory is $3.09 billion

Liabilities

Total liabilities

$8.41B
REGN annual total liabilities is $8.41 billion

Long term liabilities

$4.46B
REGN annual total long term liabilities is $4.46 billion

Current liabilities

$3.94B
REGN annual total current liabilities is $3.94 billion

Accounts payable

$789.50M
REGN annual accounts payable is $789.50 million

Debt

Total debt

$2.70B
REGN annual total debt is $2.70 billion

Total debt 1-year change

+0.06%
REGN annual total debt is up +0.06% year-on-year

Long term debt

$2.70B
REGN annual long term debt is $2.70 billion

Short term debt

-
REGN annual short term debt value is unknown

Equity & Capital

Shareholders equity

$29.35B
REGN annual stockholders equity is $29.35 billion

Book value

$29.35B
REGN annual book value is $29.35 billion

Retained earnings

$31.67B
REGN annual retained earnings is $31.67 billion

Working capital

$14.72B
REGN annual working capital is $14.72 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.42B
REGN annual cash flow from operations is $4.42 billion

Cash from operations 1-year change

-3.78%
REGN annual cash flow from operations is down -3.78% year-on-year

Cash from investing

-$2.47B
REGN annual cash flow from investing activities is -$2.47 billion

Cash from investing 1-year change

+22.51%
REGN annual cash flow from investing activities is up +22.51% year-on-year

Cash from financing

-$2.20B
REGN annual cash flow from financing activities is -$2.20 billion

Cash from financing 1-year change

-22.93%
REGN annual cash flow from financing activities is down -22.93% year-on-year

CAPEX

CAPEX

$881.60M
REGN annual capital expenditures is $881.60 million

CAPEX 1-year change

-4.84%
REGN annual capital expenditures is down -4.84% year-on-year

Free Cash Flow

Free cash flow

$3.54B
REGN annual free cash flow is $3.54 billion

Free cash flow 1-year change

-3.51%
REGN annual free cash flow is down -3.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

86.13%
REGN annual gross profit margin is 86.13%

Operating margin

28.81%
REGN annual operating profit margin is 28.81%

Net margin

31.07%
REGN annual net profit margin is 31.07%

ROA & ROE

ROA

12.46%
REGN annual return on assets is 12.46%

ROE

15.95%
REGN annual return on equity is 15.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

15.67
REGN price to earnings ratio is 15.67

PE ratio Sector rank

27.94%
REGN price to earnings ratio is higher than 27.94% of companies in Healthcare sector

PB Ratio

PB ratio

2.23
REGN price to book ratio is 2.23

PB ratio Sector rank

63.57%
REGN price to book ratio is higher than 63.57% of companies in Healthcare sector

PS Ratio

PS ratio

4.62
REGN price to sales ratio is 4.62

PS ratio Sector rank

62.6%
REGN price to sales ratio is higher than 62.6% of companies in Healthcare sector

Enterprise value

Enterprise value

$65.78B
REGN enterprise value is $65.78 billion

Enterprise value Sector rank

97.75%
REGN enterprise value is higher than 97.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.37
REGN EV/EBITDA is 12.37

EV/EBITDA Sector rank

84.89%
REGN EV/EBITDA is higher than 84.89% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.73
REGN annual current ratio is 4.73

Quick ratio

3.95
REGN annual quick ratio is 3.95

Leverage

Debt to equity

0.07
REGN annual debt to equity ratio is 0.07

Interest coverage ratio

87.59
REGN annual interest coverage ratio is 87.59

Risk & Stability

Piotroski F-Score

5
REGN piotroski f-score is 5

Altman Z-Score

7.12
REGN altman z-score is 7.12

Analyst ratings

Recent major analysts updates

Apr 23, 25 Truist Securities
Buy
Apr 22, 25 Canaccord Genuity
Buy
Apr 17, 25 Canaccord Genuity
Hold
Apr 17, 25 B of A Securities
Underperform
Apr 14, 25 Goldman Sachs
Buy
Mar 31, 25 JP Morgan
Overweight
Feb 5, 25 Leerink Partners
Outperform
Feb 5, 25 Baird
Neutral
Jan 28, 25 Citigroup
Neutral
Jan 27, 25 Piper Sandler
Overweight

Institutional Ownership

Similar stocks

ZTS logo
Zoetis (ZTS)
BDX logo
Becton Dickinson and Company (BDX)
GSK logo
GSK (GSK)
COR logo
Cencora (COR)
CVS logo
CVS Health (CVS)
TAK logo
Takeda Pharmaceutical Company Limited (TAK)
HCA logo
HCA Healthcare (HCA)
ALC logo
Alcon (ALC)
HLN logo
Haleon (HLN)
  • What is the ticker symbol for Regeneron Pharmaceuticals?
  • Does Regeneron Pharmaceuticals pay dividends?
  • What sector is Regeneron Pharmaceuticals in?
  • What industry is Regeneron Pharmaceuticals in?
  • What country is Regeneron Pharmaceuticals based in?
  • When did Regeneron Pharmaceuticals go public?
  • Is Regeneron Pharmaceuticals in the S&P 500?
  • Is Regeneron Pharmaceuticals in the NASDAQ 100?
  • Is Regeneron Pharmaceuticals in the Dow Jones?
  • When was Regeneron Pharmaceuticals's last earnings report?
  • When does Regeneron Pharmaceuticals report earnings?
  • Should I buy Regeneron Pharmaceuticals stock now?

What is the ticker symbol for Regeneron Pharmaceuticals?

The ticker symbol for Regeneron Pharmaceuticals is NASDAQ:REGN

Does Regeneron Pharmaceuticals pay dividends?

Yes, Regeneron Pharmaceuticals pays dividends. The last payment was $0.88, with an ex-dividend date on February 20, 2025

What sector is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is in the Healthcare sector

What industry is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is in the Biotechnology industry

What country is Regeneron Pharmaceuticals based in?

Regeneron Pharmaceuticals is headquartered in United States

When did Regeneron Pharmaceuticals go public?

Regeneron Pharmaceuticals's initial public offering (IPO) was on April 2, 1991

Is Regeneron Pharmaceuticals in the S&P 500?

Yes, Regeneron Pharmaceuticals is included in the S&P 500 index

Is Regeneron Pharmaceuticals in the NASDAQ 100?

Yes, Regeneron Pharmaceuticals is included in the NASDAQ 100 index

Is Regeneron Pharmaceuticals in the Dow Jones?

No, Regeneron Pharmaceuticals is not included in the Dow Jones index

When was Regeneron Pharmaceuticals's last earnings report?

Regeneron Pharmaceuticals's most recent earnings report was on Feb 4, 2025

When does Regeneron Pharmaceuticals report earnings?

The next expected earnings date for Regeneron Pharmaceuticals is Apr 29, 2025

Should I buy Regeneron Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page